ICMI 2015

F.126 Pulmonary Cellular Immune Responses to RSV infection is Associated with Concomitant Lung Damage and Differential Lymphocytic and Macrophage Activation in Different Age Groups of Hosts

Friday, July 17, 2015
Grand Hall and Gallery, Ground Floor & 1st Floor (Maritim Hotel)
Kainath Durre, MS , Touro University Nevada College of Osteopathic Medicine, Henderson, NV
Omar Qureshi , Touro University Nevada College of Osteopathic Medicine, Henderson, NV
Mahboob Qureshi, MD, PhD , Touro University Nevada College of Osteopathic Medicine, Henderson, NV
RSV infection causes bronchiolitis and pneumonia in young infants with increased mortality in this age group. Survivors predispose to susceptibility to asthma. In our present study, using a mouse model of BALB/C and NKT-/- mice, we examined the pulmonary responses to RSV infection in the very young hosts as opposed to relatively older hosts. We also examined the effects of exogenous osteopontin (OPN) administration on the alveolar cellular constitution by direct microscopy and flowcytometry and the role of NKT cells in this process. Pulmonary damage was assessed by measuring the Lactic Dehydrogenase (LDH) levels in the BALF by ELISA. Microscopy revealed a decreased lymphocyte response in the bronchoalevolar lavage fluid (BALF) of RSV-infected-4-day- old pups as compared to that of -14- and -20-day-old mice; but an enhanced neutrophil response, which was associated with increased LDH levels. Flowcytometry revealed that administration of OPN had downregulatory effects on lung lymphocyte (CD4+ and CD8+) responses in all age groups with proportional upregulation of lung macrophage (CD11bmed/hi, CD11Clo/-) responses. This effect was less pronounced in the older age groups. Additionally, activation of macrophages, as indicated by MHCII expression, was NKT dependent.  Moreover, RSV- infection significantly inhibited lung CD8+ T cell activation as indicated by decreased CD44 expression, which was recovered by OPN administration.  Understanding the underlying mechanisms of RSV-infection induced differential immune responses and OPN-mediated immunomodulations in different age groups may help develop newer therapeutic strategies.